Immunotherapy company Harpoon Therapeutics has won a $70 million Series C funding round, with which it plans to expand its TriTAC and ProTriTAC platforms, the latter of which was unveiled just days…
![](https://redherring.wpenginepowered.com/wp-content/uploads/2018/11/Screen-Shot-2018-11-12-at-12.33.54-PM-150x150.png)
![](https://redherring.wpenginepowered.com/wp-content/uploads/2018/11/Screen-Shot-2018-11-12-at-12.33.54-PM.png)
THE BUSINESS OF TECHNOLOGY
Immunotherapy company Harpoon Therapeutics has won a $70 million Series C funding round, with which it plans to expand its TriTAC and ProTriTAC platforms, the latter of which was unveiled just days…
It is a centuries-old image of good science: the lab-coated expert, hunched over a microscope analyzing a glass slide. Proscia wants to resign it to history – at least, when it comes…